|
1
|
Chen CM: Therapy for neonatal
hyperoxia-induced lung injury. Pediatr Neonatol. 55:329–330.
2014.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Crapo JD, Barry BE, Foscue HA and
Shelburne J: Structural and biochemical changes in rat lungs
occurring during exposures to lethal and adaptive dose of oxygen.
Am Rev Respir Dis. 122:123–143. 1980.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Reddy GP: Cell cycle: Regulatory events in
G1->S transition of mammalian cells. J Cell Biochem. 54:379–386.
1994.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Al-Khalaf HH, Colak D, Al-Saif M,
Al-Bakheet A, Hendrayani SF, Al-Yousef N, Kaya N, Khabar KS and
Aboussekhra A: p16(INK4a) positively regulates cyclin D1 and E2F1
through negative control of AUF1. PLoS One.
6(e21111)2011.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Vogelstein B and Kinzler KW: Cancer genes
and the pathways they control. Nat Med. 10:789–799. 2004.PubMed/NCBI View
Article : Google Scholar
|
|
6
|
Haller F, Löbke C, Ruschhaupt M, Cameron
S, Schulten HJ, Schwager S, von Heydebreck A, Gunawan B, Langer C,
Ramadori G, et al: Loss of 9p leads to p16(INK4A) down-regulation
and enables RB/E2F1-dependent cell cycle promotion in
gastrointestinal stromal tumours (GISTs). J Pathol. 215:253–262.
2008.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Wu Z and Yu Q: E2F1-mediated apoptosis as
a target of cancer therapy. Curr Mol Pharmacol. 2:149–160.
2009.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Giacinti C and Giordano A: RB and cell
cycle progression. Oncogene. 25:5220–5227. 2006.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Tyagi E, Liu B, Li C, Liu T, Rutter J and
Grossman D: Loss of p16 INK4A stimulates aberrant mitochondrial
biogenesis through a CDK4/Rb-independent pathway. Oncotarget.
8:55848–55862. 2017.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Zhao SM, Wu HM, Cao ML and Hna D: Primary
culture of lung fibroblasts from hyperoxia-exposed rats and a
proliferative characteristics study. Cytotechnology. 70:751–760.
2018.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Zhao S, Cao M, Wu H, Hu Y and Xue X:
5-aza-2'-deoxycytidine inhibits the proliferation of lung
fibroblasts in neonatal rats exposed to hyperoxia. Pediatr
Neonatol. 58:122–127. 2017.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Chen X, Zhang X and Pan J: Effect of
montelukast on bronchopulmonary dysplasia (BPD) and related
mechanisms. Med Sci Monit. 25:1886–1893. 2019.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Qi XJ, Ning W, Xu F, Dang HX, Fang F and
Li J: Fasudil, an inhibitor of Rho-associated coiled-coil kinase,
attenuates hyperoxia-induced pulmonary fibrosis in neonatal rats.
Int J Clin Exp Pathol. 8:12140–12150. 2015.PubMed/NCBI
|
|
14
|
Hu Y, Fu J and Xue X: Association of the
proliferation of lung fibroblasts with the ERK1/2 signaling pathway
in neonatal rats with hyperoxia-induced lung fibrosis. Exp Ther
Med. 17:701–708. 2019.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Herman JG, Graff JR, Myohanen S, Nelkin BD
and Baylin SB: Methylation specific PCR: A novel PCR assay for
methylation status of CpG islands. Proc Natl Acad Sci USA.
93:9821–9826. 1996.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Huang Y, Wu G, Fan H, Ye J and Liu X:
Electroacupuncture promotes chondrocyte proliferation via
accelerated G1/S transition in the cell cycle. Int JMol Med.
31:1443–1448. 2013.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Sharpless NE and DePinho RA: The INK4A/ARF
locus and its two gene products. Curr Opin Genet Dev. 9:22–30.
1999.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Williams RT, Barnhill LM, Kuo HH, Lin WD,
Batova A, Yu AL and Diccianni MB: Chimeras of p14ARF and p16:
Functional hybrids with the ability to arrest growth. PLoS One.
9(e88219)2014.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Gil J and Peters G: Regulation of the
INK4b-ARF-INK4a tumour suppressor locus: All for one or one for
all. Nat Rev Mol Cell Biol. 7:667–677. 2006.PubMed/NCBI View
Article : Google Scholar
|
|
20
|
Sharpless NE: INK4a/ARF: A multifunctional
tumor suppressor locus. Mutat Res. 576:22–38. 2005.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Yue X, Fu J, Xue X, Gao H, Liu D, Zong Z,
Wang W and Yuan Z: Detection of p16 promoter methylation in
premature rats with chronic lung disease induced by hyperoxia.
Pediatr Int. 52:520–526. 2010.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Rayess H, Wang MB and Srivatsan ES:
Cellular senescence and tumor suppressor gene p16. Int J Cancer.
130:1715–1725. 2012.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Thompson JF, Scolyer RA and Kefford RF:
Cutaneous melanoma. Lancet. 365:687–701. 2005.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Myong NH: Cyclin D1 overexpression, p16
loss, and pRb inactivation play a key role in pulmonary
carcinogenesis and have a prognostic implication for the long-term
survival in non-small cell lung carcinoma patients. Cancer Res
Treat. 40:45–52. 2008.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Dobashi Y, Goto A, Fukayama M, Abe A and
Ooi A: Overexpression of cdk4/cyclin D1, a possible mediator of
apoptosis and an indicator of prognosis in human primary lung
carcinoma. Int J Cancer. 110:532–541. 2004.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Mittnacht S: The retinoblastoma
protein-from bench to bedside. Eur J Cell Biol. 84:97–107.
2005.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Wang X, Huang K and Xu LN: Interaction
among Rb/p16, Rb/E2F1 and HDAC1 proteins in gallbladder carcinoma.
J Huazhong Univ Sci Technolog Med Sci. 29:729–731. 2009.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Haluska FG, Tsao H, Wu H, Haluska FS,
Lazar A and Goel V: Genetic alterations in signaling pathways in
melanoma. Clin Cancer Res. 12:2301s–2307s. 2006.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Palmieri G, Capone M, Ascierto ML,
Gentilcore G, Stroncek DF, Casula M, Sini MC, Palla M, Mozzillo N
and Ascierto PA: Main roads to melanoma. J Transl Med.
7(86)2009.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Wikman H and Kettunen E: Regulation of the
G1/S phase of the cell cycle and alterations in the RB pathway in
human lung cancer. Expert Rev Anticancer Ther. 6:515–530.
2006.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Thomas NS, Pizzey AR, Tiwari S, Williams
CD and Yang J: p130, p107, and pRb are differentially regulated in
proliferating cells and during cell cycle arrest by
alpha-interferon. J Biol Chem. 273:23659–23667. 1998.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Clijsters L, Hoencamp C, Calis JJA, Marzio
A, Handgraaf SM, Cuitino MC, Rosenberg BR, Leone G and Pagano M:
Cyclin F controls cell-cycle transcriptional outputs by directing
the degradation of the three activator E2Fs. Mol Cell.
74:1264–1277.e7. 2019.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Stanelle J, Stiewe T, Theseling CC, Peter
M and Pützer BM: Gene expression changes in response to E2F1
activition. Nucleic Acides Res. 30:1859–1867. 2002.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Han S, Park K, Bae BN, Kim KH, Kim HJ, Kim
YD and Kim HY: E2F1expression is related with the poor survival of
lymph node-positive breast cancer patients treated with
fluorouracil, doxorubicin and cyclophosphamide. Breast Cancer Res
Treat. 82:11–16. 2003.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Eymin B, Gazzeri S, Brambilla C and
Brambilla E: Distinct pattern of E2F1 expression in human lung
tumours: E2F1 is upregulated in small cell lung carcinomal.
Oncogene. 20:1678–1687. 2001.PubMed/NCBI View Article : Google Scholar
|
